Mineralys Therapeutics Announces Positive Topline Phase 2 Data for MLS-101 in the Target-HTN Trial Evaluating the Treatment of Uncontrolled and Resistant Hypertension

PHILADELPHIA, Nov. 16, 2022 /PRNewswire/ -- Mineralys Therapeutics, Inc., a private, clinical-stage biopharmaceutical company committed to developing a novel therapy for the treatment of hypertension and associated cardiovascular diseases, today announced topline results from the Phase 2 Target-HTN trial in individuals with uncontrolled and resistant hypertension. MLS-101, a highly selective investigational aldosterone synthase inhibitor, at doses of 50 mg and 100 mg once daily (QD), met its primary endpoint with statistically significant and clinically meaningful reduction in systolic blood pressure (SBP) in inadequately controlled hypertensive patients on at least two background antihypertensive medications.

Read More
Matt Paulmineralys
TerraGo StreetlightOps Awarded Sustainability Product of the Year

STERLING, Va. — The Business Intelligence Group named TerraGo StreetlightOps as Product of the Year in the 2022 Sustainability Awards program. TerraGo’s StreetlightOps software is being used to deploy and manage smart LED streetlight networks, replacing inefficient legacy lighting on some of the largest smart city and utility projects around the world.

Read More
Matt Paulterrago
5 Best Full-stack Monitoring Solutions for Your Modern Applications

If you want to improve your applications’ wholesome health, monitoring capabilities are something you must never ignore.

And it makes sense because modern enterprises largely depend on applications to drive their businesses. In the present scenario, application delivery and accelerated service without sacrificing quality mean a lot for your customers.

So, have you ever given a thought as to what will happen if your client systems don’t perform as they have expected?

Read More
Matt Paulzenoss
Heska to Acquire LightDeck Diagnostics to Invest in Manufacturing Capabilities and Accelerate Research and Development Efforts

LOVELAND, Colo., Sept. 12, 2022 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty solutions, announced today that the Company has entered a definitive agreement to acquire 100% of the share capital of MBio Diagnostics, Inc. d/b/a LightDeck Diagnostics ("LightDeck"), a pioneer in innovative planar waveguide fluorescence immunoassay diagnostics with strong manufacturing and specialized production capabilities (the "Acquisition").

Read More
Matt Paullightdeck
Legence Acquires Black Bear Energy, Strengthening Capabilities for Rapid Decarbonization in Buildings

SAN JOSE, Calif., July 19, 2022 (GLOBE NEWSWIRE) -- Legence, an Energy Transition Accelerator™ and leader in building efficiency, has announced the acquisition of Black Bear Energy. Black Bear’s addition to Legence’s rapidly growing portfolio expands the firm’s renewable energy procurement services and further strengthens its capabilities for decarbonization. The announcement comes on the heels of two additional acquisitions and a new brand launch that integrates an experienced legion of best-in-class companies committed to making the spaces we occupy more efficient, healthy and sustainable.

Read More
The REITs Solar Opportunity

The achievable value of onsite #solar is now so large, that price targets of publicly traded REITs are being increased solely based on the opportunity alone. Last month Morgan Stanley published a collaborative report from their REIT, cleantech and utilities analyst teams. Click “Read More” to access a PDF of the report. Their conclusion; The TAM for rooftop solar on commercial real estate is $490 million and justifies increasing targets on many of the REITs they cover. On Tuesday, Black Bear’s CEO & Founder Drew Torbin joined Richard Hill and Stephen Byrd from Morgan Stanley to discuss their findings and the massive opportunity (link to webcast in the title of article). Hats off to the analyst team who compiled this study.

Read More